# Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

> **NCT00003832** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 75 (actual)

## Conditions studied

- Stage I Prostate Cancer
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer

## Interventions

- **DRUG:** bromodeoxyuridine
- **PROCEDURE:** conventional surgery
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00003832
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2002-06
- **Final completion:** —
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003832, "Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*